A novel m6A-related prognostic signature for predicting the overall survival of hepatocellular carcinoma patients.
Ontology highlight
ABSTRACT: Liver hepatocellular carcinoma (LIHC) comprises most cases of liver cancer with a poor prognosis. N6 -methyladenosine (m6A) plays important biological functions in cancers. Thus, the present research was aimed to determine biomarkers of m6A regulators that could effectively predict the prognosis of LIHC patients. Based on the data collected from the Cancer Genome Atlas (TCGA) database, the correlation between the mRNA expression levels and copy number variation (CNV) patterns were determined. Higher mRNA expression resulted from the increasing number of 9 genes. Using the univariate Cox regression analysis, 11 m6A regulators that had close correlations with the LIHC prognosis were identified. In addition, under the support of the multivariate Cox regression models and the least
SUBMITTER: Xie S
PROVIDER: S-EPMC8849219 | biostudies-literature | 2022 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA